FIELD: biotechnology, genetic engineering, micribiological and medicinal industry. SUBSTANCE: method involves transformation of the strain of yeast p4-1-GRF18 with recombinant plasmid DNA constructed in vitro and containing encoding moiety of human beta-interferon gene (with exception of region encoding signal peptide) and the strain p4-1-GRF18(pHBI) is obtained that is a producer of human fibroblast interferon. The prepared strain of yeast Saccharomyces cerevisiae p4-1-GRF18(pHBI) is deposited in All- Russian collection of industrial microorganisms at number VKPM-Y-2286. EFFECT: enhanced level of synthesis of human fibroblast interferon. 3 cl, 2 dwg
Authors
Dates
2002-02-27—Published
1998-04-07—Filed